| PATIENTS CARACTERISTICS / RISK FACTORS |
Total Limbs (n = 152). |
Group NN Limbs (n = 43) |
Group MN Limbs (n = 70) |
Group SN Limbs (n = 39) |
| Age > 70 years |
n = 84 (55%) |
n = 25 (58%) |
n = 39 (56%) |
n = 20 (51%) |
| Hypertension |
n = 132 (87%) |
n = 39 (90%) |
n = 57 (81%) |
n = 36 (92%) |
| Smoking |
n = 65 (42%) |
n = 20 (46%) |
n = 27 (39%) |
n = 18 (46%) |
| Coronary Disease |
n = 128 (84%) |
n = 38 (88%) |
n = 56 (80%) |
n = 34 (87%) |
| Chronic Renal Insufficiency |
n = 60 (39%) |
n = 17 (39%) |
n = 27 (38%) |
n = 16 (41%) |
| End Stage Renal Disease/Dialysis |
n = 29 (19%) |
n = 6 (14%) |
n = 14 (20%) |
n = 9 (23%) |
| Hypercholesterolemia |
n = 96 (63%) |
n = 29 (67%) |
n = 44 (63%) |
n = 23 (59%) |
| Cerebrovascular disease |
n = 33 (22%) |
n = 9 (21%) |
n = 15 (21%) |
n = 9 (23%) |
| Retinopathy |
n = 99 (65%) |
n = 15 (35%) |
n = 50 (71%) |
n = 34 (87%) |
| LOCAL FEATURES IN TREATED LIMBS |
Total Limbs |
NN. |
MN. |
SN. |
| Diseased Artery > 10 cm |
n = 67 (44%) |
n = 20 (46%) |
n = 29 (41%) |
n = 18 (46%) |
| Spread of Calcifications > 3cm |
n = 57 (37%) |
n = 15 (35%) |
n = 26 (37%) |
n = 16 (41%) |
| Associated Chr. Venuous Insufficiency |
n = 21 (14%) |
n = 5 (12%) |
n = 11 (15%) |
n = 5 (13%) |
| Bedridden |
n = 15 (9%) |
n = 4 (9%) |
n = 7 (10%) |
n = 4 (10%) |
| TASC "B" lesions |
n = 13 (8%) |
n =5 (12%) |
n = 6 (9%) |
n = 2 (5%) |
| TASC "C" lesions |
n = 62 (41%) |
n = 15 (35%) |
n = 31 (44%) |
n = 16 (41%) |
| TASC "D" lesions |
n = 77 (51%) |
n = 21 (48%) |
n = 33 (47%) |
n = 23 (59%) |
| Wagner grade 1-2. |
n = 57 (37%) |
n = 18 (42%) |
n = 25 (36%) |
n = 14 (36%) |
| Wagner grade 3-4. |
n = 95 (63%) |
n = 25 (58%) |
n = 44 (64%) |
n = 26 (66%) |
| Ulcers < 10 mm2 |
n = 44 (29%) |
n = 14 (33%) |
n = 20 (29%) |
n = 10 (26%) |
| Ulcers > 10 mm2 |
n = 108 (71%) |
n = 29 (67%) |
n = 50 (71%) |
n = 29 (74%) |
